Clinical Time and Temporal Dynamics Study (CLIN-TIME)
Part of paid clinical trials in New York, New York.
- Sponsor
- Truway Health, Inc.
- Study ID
- NCT07812831
- Status
- Enrolling By Invitation
Conditions
- Biomarkers
- Cardio-pulmonary
- Clinical Outcomes
- Drugs of Abuse
- Epidemic Disease
- Health Risks
- Longitudinal Studies
- Pandemic
- Population
- Population Groups
- Predictive Value of Tests
- Prospective Studies
- Sex Behavior
- Sex Characteristics
- Sex Hormone
- Surgical
- Telemedicine
- Time Efficiency
- Time Management
- Time Perception
- Time Reaction
- Time of Death
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- No Study-Assigned Intervention — OTHERThis is a prospective observational study with no protocol-assigned drug, biologic, device, behavioral intervention, or other therapeutic intervention. Participants receive clinical care according to usual practice and applicable clinical decisions. The study observes and analyzes longitudinal clinical and physiologic data to characterize temporal dynamics and their association with clinically meaningful outcomes. Data collection may include routinely available clinical measurements, laboratory results, imaging-derived measurements, patient-reported information, and remote or digital health measurements when permitted by the protocol.
Study Details
TH-CLINICAL-TIME is a prospective, longitudinal observational study evaluating how changes in clinical measurements over time may help researchers better understand patient health trajectories and clinically meaningful outcomes. The study will examine patterns such as changes from an individual's baseline, rate of change, persistence of abnormalities, variability, recurrence, and recovery following clinical events. Data may include routinely collected clinical measurements, physiologic observations, laboratory results, cardiac measurements, imaging-derived measurements, patient-reported information, and remote or digital health data when available and permitted by the study protocol. The study will investigate whether these temporal patterns provide additional information beyond individual measurements taken at a single point in time. The planned study horizon extends from 2026 through 2076, while individual participant follow-up will occur according to the approved study schedule, consent, and applicable requirements.
Key Dates
- First listed
- Sep 10, 2026
- Start date
- Sep 1, 2026
- Status verified
- Sep 2026
- Primary completion
- Sep 1, 2076
- Completion
- Sep 1, 2076
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Clinical Time Longitudinal CohortParticipants enrolled in this prospective observational cohort will be followed longitudinally according to the approved study schedule. The cohort will be evaluated for temporal clinical dynamics, including changes from individualized baseline, rate and acceleration of change, persistence, variability, recurrence, temporal sequence, and recovery following clinically meaningful events. Analyses will integrate available longitudinal clinical, physiologic, laboratory, imaging-derived, patient-reported, and remote or digital health measurements when permitted by the study protocol. No experimental intervention is assigned by the study.
Primary Outcome Measure
Time-Dependent Predictive Discrimination of Clinically Meaningful Patient Outcomes [ Time Frame: At baseline and at 30 days, 90 days, 6 months, and 12 months after enrollment. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Truway Health, Inc. | New York | New York | 10016 | - |
Find similar trials in New York, NY
Related Studies
- Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)Recruiting · Oncology Center of Biochemical Education And Research · New York, New York
- Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory FailureRecruiting · University of Colorado, Denver · Aurora, Colorado
- ANCHORS Alcohol & Sexual Health Study: UH3 ProjectPHASE4 · Recruiting · University of Florida · Gainesville, Florida
- COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History StudyRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland